SHORT-COURSE RADIATION THERAPY, NEOADJUVANT BEVACIZUMAB, CAPECITABINE AND OXALIPLATIN, AND RADICAL RESECTION OF PRIMARY TUMOUR AND METASTASES IN PRIMARY STAGE IV RECTAL CANCER: A PHASE II MULTICENTER STUDY OF THE DUTCH COLORECTAL CANCER GROUP